I provide the theoretical basis for an error calculus for measurements of cerebral blood flow using a freely diffusible tracer substance such as xenon-133. The use of the error calculus is exemplified by a study of the effect on the error margins in measurements of gray matter blood flow from flow level, relative weight of the gray matter compartment, and use of the earliest parts of the clearance curves. The clinical value of the error calculus is illustrated by its ability to separate different sources of measurement error. As a consequence, it is possible to optimize the method for blood flow calculation from the clearance curves, depending on the type of cerebral blood flow measurement. I show that if a true picture of the regional gray matter blood flow distribution is sought, the earliest part of the clearance curves should be used. This does, however, increase the error in the estimate of the average cerebral blood flow value. (Stroke 1989;20:205-210) K nowledge of the error limits for cerebral blood flow (CBF) values measured by xenon-133 clearance is necessary for the interpretation of their significance. Usually the performance of a CBF measurement system is characterized by its "normal values," the mean and standard deviation of CBF measurements for a group of resting normal volunteers. The standard deviation of these normal CBF values contains biologic variability in brain activity due to, for example, variations in wakefulness or anxiety, and due to the measurement error, which is a function of errors in the recorded xenon-133 input and clearance curves and of the method of curve analysis. Analysis of simulated, noise-contaminated clearance curves have been used to compare the variability of the CBF results that is caused by different methods of CBF analysis.
K nowledge of the error limits for cerebral blood flow (CBF) values measured by xenon-133 clearance is necessary for the interpretation of their significance. Usually the performance of a CBF measurement system is characterized by its "normal values," the mean and standard deviation of CBF measurements for a group of resting normal volunteers. The standard deviation of these normal CBF values contains biologic variability in brain activity due to, for example, variations in wakefulness or anxiety, and due to the measurement error, which is a function of errors in the recorded xenon-133 input and clearance curves and of the method of curve analysis. Analysis of simulated, noise-contaminated clearance curves have been used to compare the variability of the CBF results that is caused by different methods of CBF analysis. 1 -3 However, the value of that approach is limited by the fact that the results reflect properties of the specific algorithms for CBF analysis rather than the general properties of all CBF methods based on measurements of the clearance of a freely diffusible tracer substance.
I introduce a method for error calculus that is founded upon the basic relations between the input and the clearance of a freely diffusible tracer substance as described by the Fick equation and its solution for xenon-133 given by Kety. 4 The error calculus enables a comparison of the influence on the measurement error of different factors in the recording and analysis of xenon-133 clearance curves. Thus, it becomes possible to optimize the method for gray matter blood flow analysis depending on whether the main object of the regional CBF measurement is a correct measurement of the flow pattern or of the mean flow level.
Methods
From the principle of conservation of matter (the Fick principle), it follows that the change in the quantity, Q t , of a tracer substance in a given tissue volume, V, is the amount transported into the tissue minus the amount cleared from the tissue. If the tracer substance is transported by the blood flow, F, we get dQ 1 /dt=Fx(C,,-C v )
where C, and C v are the concentrations of the tracer in the arterial and the venous blood, respectively. When there is a diffusion equilibrium between the concentration of the tracer in the tissue, C,, and C v , then Q=C V x A 
K m is generally time-dependent due to time dependence of H/H. Equation 4 has the well-known solution 4 (8) where n is the number of different tissue compartments. When a time segment, t,-t 2 , of the clearance curve ( Figure 1C ) is used to calculate CBF, then H becomes A=J^ Hxdr (A is the area under the clearance curve), H' becomes X=J7f dH (I is the increase of xenon-133 in the tissue), PxU becomes D=Px/ t '» Uxdr (D is the amount of xenon-133 delivered into the tissue), and K m becomes K m ,=2K i xA I /A (Km, is the average clearance constant for a given time segment and is generally timedependent).
Since all the formulas above are valid for each time point within any selected time segment, they are also valid for the entire time segment. Thus, when CBF is determined from a time segment
Equation 9 is an alternative formulation of the Fick principle; the increase in the quantity of xenon-133 in the tissue is equal to the amount delivered into the tissue minus the amount that is cleared from the tissue.
When Equation 9 is written as K m5 =D/A-I/A= D/A-[H(t2)-H(t,)]/A or
it becomes obvious (see Figure 1C ) that it is also a more general form of the height/area formula for the calculation of mean CBF. 6 When CBF is calculated using bicompartmental analysis, the clearance curve is divided into a high-flow compartment (with clearance K, and area A,) and a low-flow compartment (with clearance K 2 and area A2) ( Figure ID Equations 12 and 13 are also valid for the subdivisions of the clearance curve, which are found by bicompartmental CBF analysis. Thus, the statistical error in K, can be calculated by inserting the relevant parameters into Equation 13:
where I, is the xenon-133 increase in the high-flow compartment during the given time segment; AI, is the error in the determination of I,. When the highflow compartment is considered to be the cerebral gray matter, AK,/K, can alternatively be written as Afg/f g , where f g is the gray matter blood flow. When the error margins of a f g value from a CBF measurement with xenon-133 are calculated from Equation 14, the errors in the recording of the input and the clearance of xenon-133 must be considered separately.
Error in Input Function
When the input of xenon-133 is measured by recording its concentration in end-tidal air, a close proportionality between the concentration of the tracer in respiratory air and the arterial input to the brain is assumed 1 -3 ; the validity of this assumption is affected by factors such as the depth and regularity of respiration and a laminar and/or turbulent flow pattern of the blood that carries the tracer to the brain. Both irregular respiration and turbulent blood flow cause statistical errors in the input function, AD/D. The error due to irregular respiration can be estimated from a simultaneous end-tidal PcOj recording, but to measure the effect of turbulent blood flow, intra-arterial blood sampling is necessary. Since the error due to irregular respiration generally is considerably larger than the statistical radiation error in the recording of the input function, AD/D can be assumed to be independent of time. Recording of the concentration of xenon-133 in the lungs by means of an external detector is less affected by respiratory irregularities, but it is influenced by the concentration of xenon-133 in the bronchial air and extrapulmonary tissue. 7 The effect of these errors on individual CBF measurements cannot be determined entirely with noninvasive methods. Thus, the magnitude of AD/D is generally unknown.
Errors in Recording of Clearance Curve
The errors in recording of the clearance curve due to statistical variations in the emission of gamma quanta from xenon-133 can be expected to have a Poisson distribution. Thus, the minimal standard error (SE) of a recorded clearance curve is Vc(t), where c(t) is the number of recorded gamma quanta. This fact is used to estimate AA, and AI,. AA, is the statistical error in the estimated area of the high-flow component. Since in bicompartmental flow analysis A,=A-A 2 , it follows that the bias error is AA,=AA-AA 2 and that the statistical error is (AA,) 2 )/(t 2 -t,). Thus, the minimal statistical increase error is (AI 1 ) nun =AA/(t 2 -t,)=VA/(t 2 -t,).
To evaluate the dependence of the statistical f g error on the different flow parameters, Af^/f. was calculated from Equations 14, 15, and 16 and simulated parameter values. Also, AD/D and the clear- 
1.0
ance curve errors (AA, and AI,) were calculated separately. The simulated parameter values were obtained from clearance curves that had a gray matter compartment comprising 11 high-flow components with a Gaussian distribution (standard deviation of 0.2, see Reference 5), a mean value of f B , and a compartment weight of w g . The low-flow component was given the values K 2 =0.1 min" 1 and w 2 =l-w g . The partition coefficients were A,=0.8 and A 2 = 1.5. The clearance curves were generated according to Equation 8 . To study the effect of a prolongation of the input of the tracer substance, the clearance curves were generated from both intravenous ( Figure 1A ) and 1-minute inhalation ( Figure IB ) input functions taken from two consecutive xenon-133 CBF studies conducted at rest in a patient with no known respiratory disease. The start fit time (SFT) of the time segment of the clearance curves that was used to calculate CBF was varied between 0 and 3 minutes. The end fit time (EFT) was 11.0 minutes. AD/D (bolus error, BE) was varied between 0% and 15%, except when the effect of f g and w g on the flow error was studied; BE was then given a value of 10%. Except when their effect on the flow error was studied, f g and w g were given the values 75 ml/100 g/min and 0.5, respectively. The peak count rate of the clearance curves was kept at 300 cps, that is, 1500 counts for a 5-second interval.
All the error values I present are SE as percent of the value of the relevant parameter. Figure 2 , A and B shows the relation between the f g error and SFT. It is obvious that the L error is strongly influenced by the choice of the first time point on the clearance curve (SFT) that is included in the time segment used for calculating CBF. Except for the case of 0% error in the recording of the tracer input, the f g error is high (equal to BE) at a SFT of 0 (whole-curve analysis), decreases to a minimum at SFT of approximately 2 minutes, and increases again for later SFT values. Figure 2 , C and D shows the relation between the f g error and w g . It is an expected finding that the f g error increases at low values of w g . It is, perhaps, less expected that this effect is strongly increased at high SFT values. Note the independence of the f g error and changes in w g when SFT=0, except for very low (<0.1) w g values. Figure 3 shows the relation between the f g error and f g values. The f g error (Figure 3, A and B) , as expected, increases for low f g values, approaching the CBF of the white matter. This is mainly due to increasing sensitivity to errors in the tracer input ( Figure 3, C and D) , but also to errors in the clearance curve (Figure 3, E and F) . There is a f g error minimum at a f g value of approximately 15-30 ml/100 g/min, except when SFT=0. The f g error level for SFT=0 appears to be independent of f g for values above approximately 30 ml/100 g/min. For SFT values of 1-3 minutes, there is an increasing sensitivity to errors in the tracer input ( The duration of the tracer input appears to have little effect on the f g error. The main difference between the intravenous input function in Figure 1A and the 1-minute inhalation input function in Figure IB is the longer duration of the tracer input in the latter. The effect of prolonged input duration appears mainly to be a higher f g error for SFT values later than approximately 2 minutes (Figure 2, A and B) , especially for f g values of greater than approximately 100 ml/100 g/ min ( Figure 3, A and B) . There is no noticeable effect of the longer input duration on the relation between the f g error and w g (Figure 2 , C and D).
Results

Discussion
The object of my study is to evolve a comprehensive theory for those methods of CBF measurement that are based on the Fick principle and the use of freely diffusible tracer substances; this theoretical basis is then used for an error analysis. The error margins of the measured CBF values are shown to be the combined effect of the errors in the measurements of the tracer kinetics and of the limitations of the Fick principle. I do not account for recording errors due to radiation from the airways or to temporal misalignment between the input and clearance curves.
The kind of information that is available from the error analysis is exemplified by a calculation of error values for f g from biexponential CBF analysis. The f g error values do not include errors in the bicompartmental separation but illustrate the minimal error that can be achieved with any method for CBF analysis under the given conditions. The separation error is not included in the error calculus since it depends on the specific method used for separating the two flow compartments. 8 -10 I show that the separation error affects only the clearance and not the input part of the f g error; the separation error is independent of the other clearance errors. The main factors that influence the bicompartmental separation error are the difference between the high-and low-flow components, the EFT, and the curve height for the low-flow component. 5 Thus, the separation error can be expected to influence the f g error mainly at low f g levels and when both the input and the clearance errors are low (at a SFT of approximately 1-3 minutes).
The clinical value of the error calculus is illustrated by its ability to separate different sources of measurement error. As a consequence of this possibility of studying the error factors separately, it is possible to optimize the method for calculating CBF from the clearance curve, depending on the type of CBF measurement. Thus, for CBF measurements in which a correct global f g value and a low error margin are of primary importance, the optimal SFT of the clearance curve segment, which is used for CBF calculation, appears to be approximately 2 minutes (Figure 2, A and B) , provided there is a low bicompartmental separation error. An earlier SFT increases the error due to increasing influence from incorrect assessment of the tracer input, and a later SFT increases the error due to decreasing amount of tracer in the gray matter. When, on the other hand, the regional distribution of f g is more important, a SFT of 0 minutes (whole-curve analysis) appears to be optimal. The influence on the f g error of AD/D is then independent of f g or w g , except for extremely low f g or w g values (Figure 2 , C and D and Figure 3 , C-F).
The influence from statistical errors in the clearance curve on the f g error is minimal for a SFT of 0 minutes ( Figure 3 , E and F), which is in agreement with the reports on whole-curve analysis methods for CBF calculation.
-
8 My results, however, indicate that for errors in the tracer input of more than approximately 5%, the f g error is higher for a SFT of 0 minutes (whole-curve analysis) than for a SFT of 1-2 minutes (Figure 2, A and B) , at least when the bicompartmental separation error is low.
The f g error appears to be insensitive to the duration of tracer input for a SFT of up to approximately 2 minutes. For SFT values of >2 minutes, a longer tracer input duration increases the f g error. This finding is in principal agreement with the similar sensitivity for high-flow components in intravenous and inhalation CBF measurements found in earlier studies.
111 Thus, it may be argued that although the two methods appear to be of equal value in the study of low CBF values, the intravenous method may be preferable in studies of psychophysiological activation in normal subjects when high f g values and a prolongation of the tracer input duration (i.e., due to verbal activity) are expected.
In conclusion, the method presented here for calculating the CBF measurement errors enables an objective evaluation of how they are caused. Thus, it may become a valuable tool for creating regional CBF measurements with an optimal selection of the xenon-133 administration technique (intravenous or inhalation), recording time, and analysis parameter settings (SFT), depending on the conditions and aims of the study.
